GlassScriptPhysician profile
Richard Tang
NPI 1033744123
$2,165.76
in general payments reported to CMS, 2019-2025
14 companies · $23.10 in 2025
The $23.10 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $253 · 2022: $1,194 · 2023: $348 · 2024: $348 · 2025: $23.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $719.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $718.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $847.41 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $310.07 | 2022-2024 | |
| Aspira Women'S Health INC | $243.94 | 2021-2024 | Ova1 |
| Ucb, INC. | $199.67 | 2024 | |
| Baxter Healthcare | $169.20 | 2021-2023 | Tisseel |
| Organon LLC | $152.74 | 2021-2023 | Nexplanon |
| Hologic Sales and Service, LLC | $69.94 | 2022-2024 | Thinprep 2000 Processor, Fluent Fluid Management System, Novasure |
| Evofem Biosciences, INC. | $39.44 | 2022 | |
| Abbvie INC. | $29.30 | 2021 | |
| Smith+Nephew, INC. | $24.86 | 2022 | |
| Sumitomo Pharma America, INC. | $23.10 | 2025 | Myfembree |
| Pfizer INC. | $20.41 | 2024 | |
| Davol INC. | $18.57 | 2023 | Arista Ah Flexitip |
| Coopersurgical, INC. | $17.11 | 2024 | Paragard T 380a |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Tang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.